Phase 2/3 Efficacy and Safety of PP405 in Adult Males With NHS Type IV/V

​ Conditions: Androgenetic Alopecia

Interventions: Drug: PP405 0.05% Topical Gel; Drug: Vehicle Topical Gel

Sponsors: Pelage Pharmaceuticals, Inc.

Not yet recruiting Conditions: Androgenetic Alopecia
Interventions: Drug: PP405 0.05% Topical Gel; Drug: Vehicle Topical Gel
Sponsors: Pelage Pharmaceuticals, Inc.
Not yet recruiting